|
MDUFA Agreement Progresses, But Sticking Points Remain
FDA-industry negotiations to reauthorize the Medical Device User Fee Act (MDUFA) went down to the wire last week, as CDRH seemed destined to miss a Jan. 15 due date for sending a commitment letter to Congress.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives